Ahmetov, I.I., Mozhayskaya, I.A., Flavell, D.M., Astratenkova, I.V., Komkova, A.I., Lyuaeva, E.V., et al. (2006). PPARα gene variation and physical performance in Russian athletes.
European Journal of Applied Physiology. 97(1):103-108.
Ahmetov, I.I., Astratenkova, I.V., & Rogozkin, V.A. (2007). Association of a PPARD
Polymorphism with Human Physical Performance. Molecular Biology, 41(5), 776–780.
Alvarez, R., Requero, J.R., Batalla, A., Iqlesias, C.G., Cortina, A., Alvarez, V., et al. (1998) Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms:
association with early coronary disease. Cardiovascular Research, 40(2):375-379.
Aoyama, T., Peters, J.M., Iritani, N., Nakajima, T., Furuhata, K., Hashimoto, T., et al. (1998).
Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). Journal of Biological Chemistry, 273, 5678–5684.
Bray, M.S., Hagberg, J.M., Perusse, L., Rankinen, T., Roth, S.M., Wolfarth, B., et al. (2009) The human gene map for performance and health-related fitness phenotypes: the 2006-2007 update. Medicine and Science in Sports & Exercise, 41(1), 35-73.
Brooks, G.A., & Mercier, J. (1994). Balance of carbohydrate and lipid utilization during exercise: the "crossover" concept. Journal of Applied Physiology , 76(6), 2253-61.
Costa, A.M., Silva, A.J., Garrido, N.D., Louro, H., Oliveira, R.J., Breitenfeld, L. (2009) Association between ACE D allele and elite short distance swimming. European Journal of Applied Physiology. , 106(6), 785-790.
Carter, S.L., Rennie, C., Tarnopolsky, M.A. (2001) Substrate utilization during endurance exercise in men and women after endurance training. American journal of Physiology:
Endocrinology and Metabolism, 280, 898–907.
Desvergne, B., & Wahli, W. (1999). Peroxisome proliferator- activated receptors: nuclear control of metabolism. Endocrine Reviews,20, 649-688.
Escher, P., & Wahli, W. (2000). Peroxisome proliferator- activated receptors: insight into multiple cellular function. Mutation Research, 448, 121-138.
Flavell, D.M., Torra, I. P., Jamshidi, Y., Evans, D., Diamond, J.R., Elkeles, R.S., et al. (2000).
Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects. Diabetologia, 43, 673-680.
Flavell, D.M., Jamshidi, Y., Hawe, E., Torra, I.P., Taskinen, M.R., Frick, M.H., et al. (2002).
Peroxisome proliferator-activated receptor a gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease. Circulation, 105, 1440–1445.
Fürnsinn, C., Willson, T.M., & Brunmair, B. (2007). Peroxisome proliferator-activated eceptor-δ, a regulator of oxidative capacity, fuel switching and cholesterol transport.
Diabetologia, 50, 8-17.
Gilde, A.J., Karin, A.J.M., Willemsen, P.H.M., Chinetti, G., Feike, R., Ger, J., et al. (2003).
Peroxisome proliferator-activated receptor (PPAR) alpha and PPAR beta/delta, but not PPAR gamma, modulate the expression of genes involved in cardiac lipid metabolism.
Circulation Research, 92, 518-24.
Gulick, T., Cresci, S., Caira, T., Moore, D.D., Kelly, D.P. (1994). The peroxisome
proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proceedings of The National Academy of Sciences, 91, 11012–11016.
Hsieh, L. L., Liou, S. H., Chen, Y. H., Tsai, L. C., Yang, T., & Wu, T. N. (2000). Association between aminolevulinate dehydrogenase genotype and blood lead levels in Taiwan.
Journal of Occupational and Environmental Medicine, 42, 151-155.
Horowitz, J.F., Leone, T.C., Feng, W., Kelly, D.P., & Klein, S. (2000). Effectof endurance training on lipid metabolism in women: a Potential role for PPARα in the metabolic response to training. American Journal of Physiology, 279, 348-355.
Horton, T.J., Pagliassotti, M.J., Hobbs, K., Hill, J.O. (1998) Fuel metabolism in men and women during and after long-duration exercise. Journal of Applied Physiology, 85, 1823–1832.
Jamshidi, Y., Montgomery, H.E., Hense, H.W., Myerson, S.G., Torra, I.P., Staels, B., et al.
(2002). Peroxisome proliferator-activated receptor α gene regulates left ventricular growth in response to exercise and hypertension. Circulation, 105, 950–955.
Kelly, D.P., & Strauss, A.W. (1994). Inherited cardiomyopathies. New England Journal of Medicine, 330, 913–919.
Kendrick, Z.V., Steffen, C.A., Rumsey, W.L., Goldberg, D.I. (1987) Effect of estradiol on tissue glycogen metabolism in exercised oophorectomized rats. Journal of Applied
Physiology, 63, 492–496.
Kendrick, Z.V., Ellis, G.S. (1991) Effect of estradiol on tissue glycogen metabolism and lipid availability in exercised male rats. Journal of Applied Physiology, 71, 1694–1699.
Lee, S.S., Pineau, T., Drago, J., Lee, E.J., Owens, J.W., Kroetz, D.L., et al.(1995). Targeted disruption of the alpha isoform of the peroxisome proliferator- activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.
Molecular and Cellular Biology, 15, 3012-3022
Lucia, A., Gomez-Gallego, F., Chicharro, J.L., Hoyos, J., Celaya, K., Cordova, A., et al. (2005) Is there an association between ACE and CKMM polymorphisms and cycling
performance status during 3-week races? International Journal of Sports Medicine.
26(6), 442-447.
Luquet, S., Lopez-Soriano, J., Holst, D., Fredenrich, A., Melki, J., Rassoulzadegan, M., et al.
(2003). Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. Federation of American Societies for Experimental Biology Journal, 17, 2299–2301.
Maher, A.C., Fu, M.H., Isfort, R.J., Varbanov, A.R., Qu, X.A., Tarnopolsky, M.A. (2009) Sex differences in global mRNA content of human skeletal muscle. Public Library of Science Online, 4 (7), e6335.
Markku, V., Pirjo, N., Teemu, K., Jussi, P., Kirsti, H., Kirsi, A. et al. (2005). Single nucleotide polymorphisms in the peroxisome proliferator–activated receptor _ gene are associated with skeletal muscle glucose uptake. Diabetes, 54, 3587-3591.
Motojima, K., passilly, P., Peter, J.M., Gonzalez, F.J. & Latruffe, N. (1998). Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in tissue-and inducer-specific manner. Journal of Biological Chemistry, 273, 16710-16714.
Montgomery, H. E., Marshall, R., Hemingway, H., Myerson, S., Clarkson, P., Dollery, C. M., Hayward, M., Jubb, M., World, M., Thomas, L., Brynes, A., Saeed, N., Barnard, M., Bell, J., Prasad, K., Rayson, M., Talmud, P., Humphries, S. (1998) Human gene for physical performance. Nature, 393, 221-222.
Rankinen, T., Bray, M.S., Hagberg, J.M., Perusse, L., Roth, S.M., Wolfarth, B., et al. (2006) The human gene map for performance and health-related fitness phenotypes: the 2005 update. Medicine and Science in Sports & Exercise, 38(11), 1863-1888.
Roepstorff, C., Donsmark, M., Thiele, M., Vistisen, B., Stewart, G., et al. (2006) Sex differences in hormone-sensitive lipase expression, activity, and phosphorylation in skeletal muscle at rest and during exercise. American journal of Physiology:
Endocrinology and Metabolism, 291, 1106–1114.
Rodriguez, J. C., Gil-Gomez, G., Hegardt, F. G. and Haro, D. (1994). Peroxisome proliferator- activated receptor mediates induction of the mitochondrial 3-hydroxy-3methylglutary-CoA synthase gene by fatty acids. Journal of Biological Chemistry, 269, 18767-18772.
Russell, A.P., Feilchenfeldt, J., Schreiber, S., Praz, M., Crettenand, A., Gobelet, C., et al.
(2003). Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-{gamma} coactivator-1 and peroxisome proliferator-activated receptor-{alpha} in skeletal muscle. Diabetes, 52, 2874-2881.
Sack, M.N., Rader, T.A., Park, S., Bastin, J., McCune, SA., Kelly, D.P. (1996). Fatty acid oxidation enzyme is downregulated in the failing heart. Circulation, 94, 2837–2842.
Schoonjans, K., Watanabe, M., Suzuki, H., Mahfoudi, A., Krey, G., Wahli, W., et al. (1995).
Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is
mediated by a peroxisome proliferator response element in the C promoter. Journal of Biological Chemistry, 270, 19269-19276.
Skogsberg, J., Kannisto, K.,Cassel, T.N., Hamsten, A., Eriksson, P., Ehrenborg, E. (2003).
Evidence that peroxisome proliferator–activated receptor delta influences cholesterol metabolism in men. Journal of The American Heart Association, 23, 637-643.
Tan, N.S., Michalik, L., Desvergne, B., Wahli, W. (2003). Peroxisome proliferator-activated receptor (PPAR)-beta as a target for wound healing drugs: what is possible? American Journal of Clinical Dermatology, 4, 523-530.
Wang, Y.X., Zhang, C.L., Yu, R.T., Cho, H.K., Nelson, M.C., Bayuga-Ocampo, C.R., et al.
(2004). Regulation of muscle fiber type and running endurance by PPARdelta. Public Library of Science Biology, 2, 1532-1539.
Yang, N., MacArthur, D. G., Gulbin, J. P., Hahn, A. G., Beggs, A. H., Easteal, S., et al.
(2003). ACTN3 genotype is associated with human elite athletic performance.
American Journal of Human Genetics, 73, 627-631.